Quick Takeaways
- INCY - INCYTE CORP has 37 insiders with reported activity on this page.
- Net insider value flow over the last year: -$40,077,982.
- Recent transaction rows are available for direct filing-level review.
- Info
- Significant Ownership
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 37 Insiders of INCYTE CORP
- Symbol
- INCY on Nasdaq
- Location
- Wilmington, DE
What Changed
- Buy value: ; sell value: $40,077,981.
- Net share flow: -408,575.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$40,077,982.
Buys
$0
Shares: 0
Insiders: 0
Sells
$40,077,982
Shares: 408,575
Insiders: 11
Net
-$40,077,982
Shares: -408,575
Insiders: -11
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 37,335 | $0 | $3,642,966 | -$3,642,966 |
| 3-6 | 0 | 314,396 | $0 | $32,454,621 | -$32,454,621 |
| 6-9 | 0 | 33,316 | $0 | $2,381,407 | -$2,381,407 |
| 9-12 | 0 | 23,528 | $0 | $1,598,988 | -$1,598,988 |
INCYTE CORP executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC | Director, 10%+ Owner | $2,811,972,812 | Mixed | 31 Mar 2026 | ||
| Baker Brothers Life Sciences LP | Director, 10%+ Owner | $2,811,972,812 | Mixed | 31 Mar 2026 | ||
| 667, L.P. | Director, 10%+ Owner | $2,811,972,812 | Mixed | 31 Mar 2026 | ||
| Julian C. Baker | Director, 10%+ Owner | $2,811,972,812 | Mixed | 31 Mar 2026 | ||
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $2,811,972,812 | Mixed | 31 Mar 2026 | ||
| Felix Baker | Director, 10%+ Owner | $2,811,972,812 | Mixed | 31 Mar 2026 | ||
| Herve Hoppenot | Director | $31,601,850 | -$19,773,750 | -38% | Mixed | 08 Dec 2025 |
| Pablo J. Cagnoni | President, R&D | $22,127,552 | -$3,642,966 | -14% | Filing P/S | 17 Mar 2026 |
| Christiana Stamoulis | EVP & Chief Financial Officer | $8,564,187 | Mixed | 14 Jul 2025 | ||
| Paula J. Swain | EVP, Human Resources | $7,251,424 | Mixed | 14 Jul 2025 | ||
| Mohamed Khairie Issa | EVP, Head of US Oncology | $7,213,017 | -$1,184,064 | -14% | Filing P/S | 16 Jan 2026 |
| Wenqing Yao | EVP, Head of Discovery Chem | $6,062,363 | Mixed | 02 Jul 2021 | ||
| Patrick A. Mayes | EVP & Chief Scientific Officer | $5,697,444 | -$554,965 | -8.9% | Filing P/S | 16 Jan 2026 |
| Maria E. Pasquale | EVP & General Counsel | $4,288,026 | Mixed | 14 Jul 2023 | ||
| Lee Heeson | EVP, Head of Incyte Intl | $3,905,669 | -$289,017 | -6.9% | Mixed | 02 Feb 2026 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | $3,626,532 | Mixed | 14 Jul 2023 | ||
| Michael James Morrissey | EVP, Head of Tech. Operations | $3,497,453 | -$5,675,002 | -62% | Mixed | 02 Feb 2026 |
| Steven H. Stein | EVP & Chief Medical Officer | $3,478,445 | -$5,724,778 | -62% | Filing P/S | 16 Jan 2026 |
| Sheila A. Denton | EVP & General Counsel | $2,772,740 | -$1,057,923 | -28% | Filing P/S | 17 Nov 2025 |
| Vijay K. Iyengar | Evp, Gmapps | $2,771,314 | -$736,698 | -21% | Filing P/S | 16 Jul 2025 |
| William Meury | Chief Executive Officer, Director, President | $2,498,911 | Mixed | 02 Jul 2025 | ||
| Barry P. Flannelly | EVP & General Manager US | $2,402,785 | -$917,915 | -28% | Filing P/S | 16 Jul 2025 |
| Paul J. Clancy | Director | $2,344,898 | Mixed | 31 Mar 2026 | ||
| Thomas Tray | Principal Accounting Officer | $2,297,300 | -$520,904 | -18% | Filing P/S | 16 Jan 2026 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | $2,269,644 | Filing P/S | 12 Sep 2024 | ||
| Edmund Harrigan | Director | $2,086,219 | Mixed | 31 Mar 2026 | ||
| Matteo Trotta | EVP, GM, Dermatology US | $1,469,895 | Mixed | 25 Mar 2026 | ||
| Jean J. Bienaime | Director | $1,268,174 | Mixed | 10 Jun 2025 | ||
| Jacqualyn A. Fouse | Director | $1,175,987 | Mixed | 10 Jun 2025 | ||
| Wendy L. Dixon | Director | $1,092,732 | Mixed | 31 Mar 2022 | ||
| Richard A. Hoffman | EVP & General Counsel | $997,811 | Mixed | 01 Dec 2025 | ||
| Katherine A. High | Director | $811,799 | Mixed | 10 Jun 2025 | ||
| David H. Gardner | EVP, Chief Strategy Officer | $789,207 | Mixed | 22 Sep 2025 | ||
| Dr. Otis W. Brawley | Director | $684,684 | Mixed | 10 Jun 2025 | ||
| Ramitpal K. Basi | EVP, Human Resources | $456,460 | Mixed | 25 Aug 2025 | ||
| Susanne Schaffert | Director | $449,620 | Mixed | 10 Jun 2025 | ||
| Paul Trower | Principal Accounting Officer | Mixed | 19 Jan 2022 |
Top shareholders of INCYTE CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13D/G
3/4/5
13F
|
Felix J. Baker · Director, 10%+ Owner · Company |
16%
|
31,213,417
|
$3,228,403,720 | $0 | 06 Feb 2026 | |
| 667, L.P. |
3/4/5
|
Director, 10%+ Owner |
14%
|
28,469,908
|
$2,811,972,812 | — | 31 Mar 2026 | |
| Baker Bros. Advisors (GP) LLC |
3/4/5
|
Director, 10%+ Owner |
14%
|
28,469,908
|
$2,811,972,812 | — | 31 Mar 2026 | |
| Baker Brothers Life Sciences LP |
3/4/5
|
Director, 10%+ Owner |
14%
|
28,469,908
|
$2,811,972,812 | — | 31 Mar 2026 | |
| Felix Baker |
3/4/5
|
Director, 10%+ Owner |
14%
|
28,469,908
|
$2,811,972,812 | — | 31 Mar 2026 | |
| Julian C. Baker |
3/4/5
|
Director, 10%+ Owner |
14%
|
28,469,908
|
$2,811,972,812 | — | 31 Mar 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
19,911,434
|
$1,966,652,336 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
18,327,923
|
$1,810,248,917 | — | 31 Dec 2025 | |
| DODGE & COX |
13F
|
Company |
6.7%
|
13,261,742
|
$1,309,862,257 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5%
from 13D/G
|
9,656,403
|
$953,762,924 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.4%
|
6,720,024
|
$663,736,788 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
4,993,012
|
$491,499,628 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
3,978,332
|
$392,939,852 | — | 31 Dec 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
2%
|
3,933,758
|
$388,537,000 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
3,473,781
|
$343,105,349 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.6%
|
3,094,460
|
$305,639,814 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
2,663,823
|
$263,105,935 | — | 31 Dec 2025 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
1.2%
|
2,480,793
|
$245,027,930 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.1%
|
2,284,317
|
$225,621,990 | — | 31 Dec 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,288,874
|
$211,926,843 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.93%
|
1,844,752
|
$182,169,000 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.9%
|
1,788,190
|
$176,620,167 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.89%
|
1,760,843
|
$173,918,463 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.87%
|
1,732,639
|
$171,132,754 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.86%
|
1,703,271
|
$168,232,077 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.79%
|
1,574,718
|
$155,534,897 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.74%
|
1,469,147
|
$145,107,657 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.73%
|
1,453,664
|
$143,578,393 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.66%
|
1,315,666
|
$130,145,237 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
1,283,694
|
$126,790,373 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.64%
|
1,276,586
|
$126,088,442 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.64%
|
1,273,170
|
$125,751,002 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.63%
|
1,246,439
|
$123,110,811 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
0.63%
|
1,244,233
|
$122,892,893 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.56%
|
1,116,382
|
$110,265,000 | — | 31 Dec 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.56%
|
1,111,193
|
$109,752,533 | — | 31 Dec 2025 | |
| Man Group plc |
13F
|
Company |
0.55%
|
1,099,329
|
$108,580,725 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.55%
|
1,098,102
|
$108,459,535 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.54%
|
1,072,491
|
$105,929,937 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.5%
|
1,003,440
|
$99,109,792 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.5%
|
1,002,249
|
$98,992,141 | — | 31 Dec 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.5%
|
992,115
|
$97,991,199 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.49%
|
978,112
|
$96,612,000 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.49%
|
965,846
|
$95,398,000 | — | 31 Dec 2025 | |
| SOUND SHORE MANAGEMENT INC /CT/ |
13F
|
Company |
0.47%
|
929,832
|
$91,839,507 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.44%
|
865,150
|
$85,454,074 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.4%
|
792,728
|
$78,297,745 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.39%
|
774,186
|
$76,466,351 | — | 31 Dec 2025 | |
| VIRGINIA RETIREMENT SYSTEMS ET Al |
13F
|
Company |
0.39%
|
768,325
|
$75,887,460 | — | 31 Dec 2025 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.38%
|
754,116
|
$74,499,120 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for INCYTE CORP
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Award | 842 | 28,188,718 | 31 Mar 2026 | See Footnotes | |||
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Award | 842 | 28,188,718 | 31 Mar 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 842 | 28,188,718 | 31 Mar 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 842 | 28,188,718 | 31 Mar 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 842 | 28,188,718 | 31 Mar 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 842 | 28,188,718 | 31 Mar 2026 | See Footnotes | |||
| Edmund Harrigan | INCY | Common Stock | Award | 1.29% | 269 | 21,122 | 31 Mar 2026 | Direct | ||
| Paul J. Clancy | INCY | Common Stock | Award | 1.13% | 265 | 23,741 | 31 Mar 2026 | Direct | ||
| Matteo Trotta | INCY | Common Stock | Tax liability | -3.48% | -537 | 14,882 | 25 Mar 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Common Stock | Sale | -7.36% | $1,759,178 | $94.24 | -18,667 | 234,800 | 17 Mar 2026 | Direct |
| Pablo J. Cagnoni | INCY | Common Stock | Options Exercise | 7.95% | 18,667 | 253,467 | 17 Mar 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Employee Stock Option (right to buy) | Options Exercise | -67.2% | -18,667 | 9,102 | 17 Mar 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Common Stock | Sale | -7.37% | $1,883,788 | $100.91 | -18,668 | 234,800 | 19 Feb 2026 | Direct |
| Pablo J. Cagnoni | INCY | Common Stock | Options Exercise | 7.95% | 18,668 | 253,468 | 19 Feb 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Employee Stock Option (right to buy) | Options Exercise | -72.2% | -18,668 | 7,182 | 19 Feb 2026 | Direct | ||
| Lee Heeson | INCY | Common Stock | Tax liability | -0.29% | -111 | 38,041 | 02 Feb 2026 | Direct | ||
| Michael James Morrissey | INCY | Common Stock | Tax liability | -0.54% | -185 | 34,065 | 02 Feb 2026 | Direct | ||
| Michael James Morrissey | INCY | Common Stock | Tax liability | -1.24% | -429 | 34,250 | 20 Jan 2026 | Direct | ||
| Lee Heeson | INCY | Common Stock | Award | 30.5% | 8,911 | 38,152 | 16 Jan 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Employee Stock Option (right to buy) | Award | 28,475 | 28,475 | 16 Jan 2026 | Direct | |||
| Steven H. Stein | INCY | Employee Stock Option (right to buy) | Award | 19,932 | 19,932 | 16 Jan 2026 | Direct | |||
| Mohamed Khairie Issa | INCY | Employee Stock Option (right to buy) | Award | 14,237 | 14,237 | 16 Jan 2026 | Direct | |||
| Matteo Trotta | INCY | Employee Stock Option (right to buy) | Award | 8,542 | 8,542 | 16 Jan 2026 | Direct | |||
| Thomas Tray | INCY | Employee Stock Option (right to buy) | Award | 2,425 | 2,425 | 16 Jan 2026 | Direct | |||
| Patrick A. Mayes | INCY | Employee Stock Option (right to buy) | Award | 4,218 | 4,218 | 16 Jan 2026 | Direct | |||
| Michael James Morrissey | INCY | Common Stock | Award | 27.2% | 7,426 | 34,679 | 16 Jan 2026 | Direct | ||
| Mohamed Khairie Issa | INCY | Common Stock | Sale | -14.1% | $1,184,064 | $109.07 | -10,856 | 66,132 | 07 Jan 2026 | Direct |
| Mohamed Khairie Issa | INCY | Common Stock | Tax liability | -9.69% | -8,264 | 76,988 | 06 Jan 2026 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Sale | -31.4% | $1,589,978 | $101.70 | -15,634 | 34,203 | 05 Jan 2026 | Direct |
| Paul J. Clancy | INCY | Common Stock | Award | 1.04% | 241 | 23,476 | 31 Dec 2025 | Direct | ||
| Edmund Harrigan | INCY | Common Stock | Award | 1.19% | 245 | 20,853 | 31 Dec 2025 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Tax liability | -21.1% | -13,292 | 49,837 | 31 Dec 2025 | Direct | ||
| Michael James Morrissey | INCY | Common Stock | Tax liability | -0.92% | -254 | 27,253 | 31 Dec 2025 | Direct | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 656 | 28,188,297 | 31 Dec 2025 | See Footnotes | |||
| Thomas Tray | INCY | Common Stock | Sale | -10.8% | $277,400 | $100.00 | -2,774 | 22,973 | 19 Dec 2025 | Direct |
| Thomas Tray | INCY | Common Stock | Options Exercise | 12.1% | 2,774 | 25,747 | 19 Dec 2025 | Direct | ||
| Thomas Tray | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -1,730 | 0 | 19 Dec 2025 | Direct | ||
| Thomas Tray | INCY | Incentive Stock Option (right to buy) | Options Exercise | -100% | -1,044 | 0 | 19 Dec 2025 | Direct | ||
| Thomas Tray | INCY | Common Stock | Sale | -2.55% | $58,950 | $98.25 | -600 | 22,973 | 18 Dec 2025 | Direct |
| Michael James Morrissey | INCY | Common Stock | Sale | -13.6% | $420,455 | $97.26 | -4,323 | 27,507 | 17 Dec 2025 | Direct |
| Michael James Morrissey | INCY | Common Stock | Sale | -62.9% | $5,254,547 | $97.29 | -54,008 | 31,830 | 16 Dec 2025 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Sale | -0.42% | $24,210 | $94.94 | -255 | 60,011 | 11 Dec 2025 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Sale | -8.44% | $530,756 | $95.58 | -5,553 | 60,266 | 10 Dec 2025 | Direct |
| Herve Hoppenot | INCY | Common Stock | Tax liability | -0.86% | -2,843 | 326,803 | 08 Dec 2025 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Sale | -24.2% | $2,060,964 | $102.51 | -20,105 | 63,129 | 02 Dec 2025 | Direct |
| Steven H. Stein | INCY | Common Stock | Tax liability | -17% | -17,093 | 83,234 | 01 Dec 2025 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Sale | -2.49% | $263,475 | $102.96 | -2,559 | 100,327 | 01 Dec 2025 | Direct |
| Michael James Morrissey | INCY | Common Stock | Tax liability | -0.38% | -326 | 85,838 | 01 Dec 2025 | Direct | ||
| Richard A. Hoffman | INCY | Common Stock | Award | 9,466 | 9,466 | 01 Dec 2025 | Direct | |||
| Richard A. Hoffman | INCY | Performance Shares | Award | 23,665 | 23,665 | 01 Dec 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.